ABCA3 and chronic myelogenous leukemia, BCR-ABL1 positive: Further analysis in chronic myeloid leukemia (CML) showed that lysosomal storage capacity was increased with increases in ABCA3 expression, indicating that ABCA3 may contribute to drug resistance by facilitating lysosomal drug sequestration[44].